Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Document › Details

CRISPR Therapeutics AG. (11/28/17). "Press Release: CRISPR Therapeutics to Participate in Upcoming Investor Conferences". Zug & Cambridge, MA.

	Region	New York, NY
	Country	United States (USA)
	Organisation	CRISPR Therapeutics AG (Nasdaq: CRSP)
	Group	CRISPR Therapeutics (Group)
	Organisation 2	Piper Jaffray & Co. (NYSE: PJC)
	Group	Piper Sandler (Group)
	Product	Barclays Gene Editing & Gene Therapy Summit 2017 New York
	Product 2	Evercore ISI BioPharma Catalyst / Deep Dive Conference 2017 Boston
	Index term	CRISPR Therapeutics–Piper Jaffray: investor conference, 201711 supply service CRISPR Therapeutics at Piper Jaffray Healthcare Conference 2017
	Index term 2	CRISPR Therapeutics–Citigroup: investor conference, 201712 supply service 1-on-1 meetings at Citi Global Healthcare Conference NY
	Person	Paganelli, Jennifer (W2O Group 201703)
	Person 2	Brinzey, Christopher F. (Chris) (Westwicke Partners 201703)

CRISPR Therapeutics (NASDAQ:CRSP), a genome editing company focused on creating transformative medicine for serious diseases, today announced that members of its senior management team are scheduled to present or host one-on-one meetings at five upcoming Investor Conferences.

29th Annual Piper Jaffray Healthcare Conference
Date: Wednesday, November 29, 2017
Fireside Chat: 1:00-1:25 PM ET

Barclays Gene Editing & Gene Therapy Summit
Date: Thursday, November 30, 2017
Presentation: 3:00-3:20 PM ET
Panel Discussion: 3:40-4:40 PM ET Gene Editing: Putting Molecular Scissors in Real Life Use

Evercore ISI BioPharma Catalyst/Deep Dive Conference
Date: Thursday, November 30, 2017
Fireside Chat: 10:15-10:35 AM ET

Citi 2017 Global Healthcare Conference
Date: Wednesday December 6, 2017
One-on-one meetings only

Guggenheim 4th Annual Boston Healthcare Conference
Date: Tuesday December 13, 2017
One-on-one meetings only

About CRISPR Therapeutics

CRISPR Therapeutics is a leading gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a revolutionary technology that allows for precise, directed changes to genomic DNA. The company's multi-disciplinary team of world-class researchers and drug developers is working to translate this technology into breakthrough human therapeutics in a number of serious diseases. Additionally, CRISPR Therapeutics has established strategic collaborations with Bayer AG and Vertex Pharmaceuticals to develop CRISPR-based therapeutics in diseases with high unmet need. The foundational CRISPR/Cas9 patent estate for human therapeutic use was licensed from the company's scientific founder Emmanuelle Charpentier, Ph.D. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts. For more information, please visit http://www.crisprtx.com.

MEDIA CONTACTS:
Jennifer Paganelli
WCG on behalf of CRISPR
+1 347-658-8290 jpaganelli@wcgworld.com

INVESTOR CONTACT:
Chris Erdman
+1 617.307.7227 chris.erdman@crisprtx.com

Chris Brinzey
Westwicke Partners for CRISPR
+1 339-970-2843 chris.brinzey@westwicke.com

Record changed: 2023-06-05

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for CRISPR Therapeutics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)